Changeflow GovPing Government & Legislation RNA Testing for Hepatitis C Amendment Determina...
Routine Rule Amended Final

RNA Testing for Hepatitis C Amendment Determination 2026

Favicon for www.legislation.gov.au AU Federal Legislative Instruments (7-day)
Published
Detected
Email

Summary

The Australian Department of Health and Aged Care has amended the Health Insurance (Section 4BA - Pathologist-Determinable Services) Determination 2025 to update Medicare Schedule items for Hepatitis C RNA testing. The amendment modifies coverage and billing requirements for pathology services under Medicare. Pathologists and pathology laboratories performing Hepatitis C RNA testing must comply with revised claiming procedures.

Published by DoHAC on legislation.gov.au . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The determination amends Schedule 1 of the Health Insurance (Section 4BA - Pathologist-Determinable Services) Determination 2025, specifically updating Medicare benefits and service descriptions related to Hepatitis C RNA testing. The amendment affects how pathologists can determine and claim eligible services under Section 4BA of the Health Insurance Act 1973.

Pathologists and pathology laboratories providing Hepatitis C RNA testing services must update their billing systems and compliance procedures to align with the revised Schedule items. These changes may affect service eligibility, claiming pathways, and rebate amounts for Hepatitis C diagnostic testing under Medicare.

What to do next

  1. Review updated Medicare Schedule items for Hepatitis C RNA testing
  2. Update pathology billing and claiming procedures to reflect amendments
  3. Ensure compliance with revised pathologist-determinable service requirements

Archived snapshot

Apr 9, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

- Interactions

Health Insurance (Section 4BA - Pathologist-Determinable Services) Amendment (Ribonucleic Acid Testing for Hepatitis C) Determination 2026

In force Administered by
- Department of Health, Disability and Ageing
This item is authorised by the following title:


View document Legislative instrument Explanatory statement Filter active Table of contents
- 1 Name
- 2 Commencement
- 3 Authority
- 4 Schedules
- Schedule 1—Amendments
- Health Insurance (Section 4BA - Pathologist-Determinable Services) Determination 2025

Named provisions

Schedule 1 — Amendments

Get daily alerts for AU Federal Legislative Instruments (7-day)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from DoHAC.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
DoHAC
Published
April 7th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
F2026L00413
Supersedes
Health Insurance (Section 4BA - Pathologist-Determinable Services) Determination 2025

Who this affects

Applies to
Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Pathology testing Hepatitis C screening Medicare claiming
Geographic scope
Australia AU

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Public Health

Get alerts for this source

We'll email you when AU Federal Legislative Instruments (7-day) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!